NDC 53808-0895

COMBIVIR

Lamivudine And Zidovudine

COMBIVIR is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by State Of Florida Doh Central Pharmacy. The primary component is Lamivudine; Zidovudine.

• Product ID: 53808-0895_30dbb679-87a4-4823-b61b-f4b9d8078955
• NDC: 53808-0895
• Product Type: Human Prescription Drug
• Proprietary Name: COMBIVIR
• Generic Name: Lamivudine And Zidovudine
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2014-01-01
• Marketing Category: NDA / NDA
• Application Number: NDA020857
• Labeler Name: State of Florida DOH Central Pharmacy
• Substance Name: LAMIVUDINE; ZIDOVUDINE
• Active Ingredient Strength: 150 mg/1; mg/1
• Pharm Classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 53808-0895-1

30 TABLET, FILM COATED in 1 BLISTER PACK (53808-0895-1)

• Marketing Start Date: 2014-01-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 53808-0895-1 [53808089501]

COMBIVIR TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA020857
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2014-01-01
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
LAMIVUDINE	150 mg/1

OpenFDA Data

• SPL SET ID: 1bc4c6c8-7e75-494e-810b-8f83135a3204
• Manufacturer:
  • State of Florida DOH Central Pharmacy
• UNII:
  • 2T8Q726O95
  • 4B9XT59T7S
• RxNorm Concept Unique ID - RxCUI:
  • 200082
  • 213088

Pharmacological Class

• Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]
• Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
• Nucleoside Analog [EXT]
• Nucleoside Reverse Transcriptase Inhibitors [MoA]

NDC Crossover Matching brand name "COMBIVIR" or generic name "Lamivudine And Zidovudine"

NDC	Brand Name	Generic Name
21695-846	COMBIVIR	lamivudine and zidovudine
49702-202	COMBIVIR	lamivudine and zidovudine
50090-0610	COMBIVIR	lamivudine and zidovudine
52959-546	COMBIVIR	lamivudine and zidovudine
53808-0895	COMBIVIR	lamivudine and zidovudine
21695-996	Lamivudine and Zidovudine	Lamivudine and Zidovudine
31722-506	LAMIVUDINE and ZIDOVUDINE	LAMIVUDINE and ZIDOVUDINE
31722-739	Lamivudine and Zidovudine	Lamivudine and Zidovudine
33342-003	Lamivudine and Zidovudine	Lamivudine and Zidovudine
42291-363	Lamivudine and Zidovudine	Lamivudine and Zidovudine
43063-346	Lamivudine and Zidovudine	Lamivudine and Zidovudine
43063-900	lamiVUDine and ZIDOVUDINE	lamiVUDine and ZIDOVUDINE
50090-3920	LAMIVUDINE and ZIDOVUDINE	LAMIVUDINE and ZIDOVUDINE
50268-456	LAMIVUDINE and ZIDOVUDINE	LAMIVUDINE and ZIDOVUDINE
50436-0597	Lamivudine and Zidovudine	Lamivudine and Zidovudine
54741-102	Lamivudine and Zidovudine	lamivudine and zidovudine
55700-096	Lamivudine and Zidovudine	Lamivudine and Zidovudine
57297-284	LAMIVUDINE AND ZIDOVUDINE	LAMIVUDINE AND ZIDOVUDINE
63629-4872	Lamivudine and Zidovudine	Lamivudine and Zidovudine
64380-707	Lamivudine and Zidovudine	Lamivudine and Zidovudine
65862-036	Lamivudine and Zidovudine	Lamivudine and Zidovudine
65862-597	Lamivudine and Zidovudine	Lamivudine and Zidovudine